A Study of Famitinib Malate in HER2-negative Metastatic Breast Cancer

Clinical trial NCT01653574 · COMPLETED

Trial details

NCT number: NCT01653574
Sponsor: Fudan University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasms

Start date: 2012-05-01
Primary completion: 2013-11-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.